NewsRx

Search our medical news database

Patents

Bioniche expands patent portfolio with three new patents

Published in Pharma Law Weekly, November 28th, 2006

Bioniche Life Sciences, Inc., (BNC) has been granted three new patents for its core proprietary Mycobacterial Cell Wall-DNA Complex (MCC) and the related oligonucleotides.

The president & CEO of Bioniche Life Sciences, Inc., Graeme McRae, noted, "Bioniche takes its patent portfolio very seriously. We have more than 300 approved patents or pending patent applications in progress, and we are constantly adding more. This ensures the maximum opportunity for returns on marketed products."

The company has been granted a patent in the U.S. entitled "Hyaluronic acid in the treatment of cancer" (U.S. Patent No. 7125858), inventors Nigel C. Phillips and Mario...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook